Breast Cancer Clinical Trial
Official title:
Evaluation of Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer Surgeries, Clinical Randomized Controlled Trial
This study investigate the effect of pre-operative ultrasound guided stellate ganglion block with local anesthetic on the frequency of neuropathic pain syndromes in the first 6-month post cancer breast surgeries with axillary dissection.
In this study Eighty Female patients with a diagnosis of breast cancer, underwent breast
surgery with axillary dissection at National Cancer Institute, Cairo University were included
in this study. Patients will be randomized into two equal comparable groups of patients.
(Group A the study group) was received pre-operative ultrasound guided stellate ganglion
block one hour before surgery and multimodal analgesia and (Group B the control group) was
received multimodal analgesia only.
The present study showed in regards to the acute pain management of the stellate ganglion
block: intraoperative hemodynamics, mean arterial blood pressure and heart rate (MABP, HR)
were statistically significant less in group A (Stellate Group) than group B (Control Group)
and this leads to significant less opioid consumption in Group A (Stellate Group) than Group
B (Control group). In the 1st 24h postoperative opioid consumption measured by number of
rescue dose of morphine 5mg IV were administered when visual analogue score was more than 4
and total requirement per 24 hours was recorded. The results show statistically significant
less opioid consumption in Group A (Stellate Group) with average visual analogue score 3.5 in
1st 24h than Group B (Control group) with average visual analogue score 5.5 in 1st 24h.
The present study showed in regards to the chronic pain management of the stellate ganglion
block that, the 6-month relative frequency of neuropathic pain syndromes, using the grading
system for neuropathic pain (GSNP) shows statistically significance lower frequency of
neuropathic pain syndromes in Group A (Stellate Group) than Group B (Control group).
Assessment of patient daily activity and functional capacity using Eastern cooperative
oncology group (ECOG) scoring showed statistically significance higher performance status
(lower numbers in the score) in Group A (Stellate Group) than Group B (Control group).
Number of patients discharged on tramadol & or Lyrica whom developed Post Mastectomy Pain
syndrome (PMPs) is statically significant lower in Group A (Stellate Group) than Group B
(Control group).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |